Profile cover photo
Profile photo
Richmond Pharmacology
50 followers -
Richmond Pharmacology is a Phase I clinical research unit based in London, UK
Richmond Pharmacology is a Phase I clinical research unit based in London, UK

50 followers
About
Posts

Post has attachment
Will be attending the EUFEMED conference in London next month 17-19th May. The theme of the conference is exploratory medicines development: innovation and risk management with an emphasis on interactive and inter-disciplinary discussion. Come and say hi, we would love to see you there!
Photo
Add a comment...

Post has attachment
New CRO unit facility welcomes first overnight patients. One month on from Richmond’s opening event, which saw leading industry bodies and stakeholders convene, the CRO has been busy settling in their first patients at the new London Bridge site. Clinical work commenced on the 25th March with volunteers commenting on the excellent transport links and fantastic new location in the heart of London Bridge.
Photo
Add a comment...

Post has attachment
Wishing you all a very Merry Christmas & a Happy New Year from everyone at Richmond Pharmacology:) #Merry #Christmas #Happy #Newyear #RichmondPharmacology
Photo
Add a comment...

Post has attachment
Its Day 1 of ‪BioTrinity 2016‬ and it's been a fun-filled day with ‪#CharlieChaplin‬ working his magic! If you are attending the meeting stop by Stand 20 and say hello!
Photo
Photo
2016-04-26
2 Photos - View album
Add a comment...

Post has attachment
We have the capacity to replace multiple sites confirmed by our rapid and on-time recruitment.

Watch our latest video: https://youtu.be/NAu6JbeOR8Y

Read more about our #patientrecruitment experience: http://www.richmondpharmacology.com/news/archive_new_story.php?id=150

#clinicaltrials   #patienttrials   #patientretention   #pharmaceuticals   #biotechnology   #lifesciences   #pharmaceuticals   #clinicalresearch  
Add a comment...

Post has attachment
Add a comment...

Post has attachment
Join us for the 36th Annual Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT) taking place 9-11 December 2015 in Tokyo, Japan.

Dr Jorg Taubel will be presenting his latest scientific poster presentation on Day 1 from 14h20 to 15h00; Investigating the effect of intravenous APD421 (Amilsulpride) and the ethnic differences between Japanese and Caucasians on cardiac conduction

The theme of this year’s meeting is "Rolling back the frontiers of clinical pharmacology and therapeutics," and its focus will be to revive the spirit of the Society’s founding days and push back the horizons of new clinical pharmacology (and therapeutics) in the 21st century. 
 
View program and register: http://jscpt2015.org/index_en.html

#clinicalpharmacology #science #clinicalresearch #ethicdifferences #Japanesebriding #TQT
Add a comment...

Post has attachment
Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval – A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity. Read full paper: http://www.plosone.org/article/Metrics/info:doi/10.1371/journal.pone.0136369 #TQT   #ECG   #QTc   #pharmaceuticals   #biotechnology   #QTc   #clinicalresearch   #clinicaltrials   #science  
Photo
Add a comment...

Post has attachment
200,000 volunteers and counting - be part of our world!
‪#‎RichmondPharmacology‬ ‪#‎clinicaltrials ‪#‎patientrecrutiment‬ ‬ ‪‪‪#‎phaseI‬ ‪#‎earlyphase‬ #‎clinicalresearch‬
Add a comment...

Post has attachment
We understand the needs of our sponsors allowing us to deliver on time, on budget with no reworking or extensions required.

Our experience in dermatology studies includes injectable, oral, topical and patch application with applications to the whole body or precise areas, which demonstrates our far reaching expertise and capabilities.

Using MHRA endorsed adaptive protocol templates enables us to run entire phase 1 programmes in one protocol without interim data submissions to regulators, saving you time and money.

We give you streamlined designs, peer-to-peer conversations and excellent regulatory contacts.

Add to this our board of scientists and clinical experts and it’s easy to see why Richmond Pharmacology is the right partner for you.

See how we can add value to your drug development program;

Email info@richmondpharmacology.com

Or visit our website: www.richmondpharmacology.com for more information
Add a comment...
Wait while more posts are being loaded